A research reference is not a compounding option
FDA explicitly states that retatrutide cannot be used in compounding under federal law. A clinical trial, supplier price or inquiry button does not create a permitted clinical supply route.
Documentation to request
Keep the research identity and proposed use distinct from any patient-treatment request. Do not substitute this listing for an approved GLP-1 medicine.
Regulatory context: FDA: unapproved GLP-1 drugs and ingredient restrictions. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.
Related guidance: Weight-loss clinic sourcing requirements. These references support a review, not a treatment recommendation or supply authorization.